ISRG Stock Recent News

For the better part of the last three years, no trend has been hotter on Wall Street than the rise of artificial intelligence (AI). Giving software and systems the tools to make split-second decisions without human oversight is a game-changer for most industries around the globe.

Intuitive Surgical wins FDA nod for its Vessel Sealer Curved, boosting the da Vinci system's precision and multifunctional capabilities.

Besides Wall Street's top-and-bottom-line estimates for Intuitive Surgical (ISRG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Intuitive Surgical's global da Vinci growth faces resistance as hospital CapEx tightens abroad, testing leasing and utilization strategies.

Are you looking for passive growth investments with staying power that you won't need to constantly monitor? That's a combination that doesn't often co-exist for any individual stock.

In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $512.06, denoting a -2.66% move from the preceding trading day.

Intuitive's latest advanced energy instrument features a unique curved tip for enhanced precision Intuitive's latest advanced energy instrument features a unique curved tip for enhanced precision

Intuitive Surgical's installed base tops 10,000, but flat utilization growth raises questions about ROI and system productivity.

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $534.65, marking a -1.8% move from the previous day.